Home » Topics » Regulatory

Regulatory
RSS

Harvard Scientific files IND for impotency treatment

May 3, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

Nasal propranolol claimed by RiboGene for angina Rx

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

DynaGen's lobeline transdermal system receives patent coverage

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

MTP-5019 data revealed at AACR

May 3, 1996

Onco TCS slated to enter phase II

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...